ArthroCare Announces Two Upcoming Presentations.

SUNNYVALE, Calif. -- CEO to Present During Thomas Weisel Partners Healthcare Tailwinds 2004 Conference; Company to Host Coblation Tonsillectomy Symposium at AAO 

ArthroCare(R) Corp. (Nasdaq:ARTC), a multi-business medical device company that develops minimally invasive surgical products, announced today details surrounding two upcoming presentations.

Healthcare Tailwinds 2004 Conference

ArthroCare will present during the Thomas Weisel Partners Healthcare Tailwinds 2004 conference in Boston. Michael Baker, president and chief executive officer for ArthroCare, will deliver the business presentation. Further details include:

--Date: Fri., Sept. 10, 2004

--Time: 1:40 p.m. EDT 

--Location: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116

--Room: Salon B

The presentation will be Webcast live and can be accessed on ArthroCare's Web site at www.arthrocare.com or at www.visualwebcaster.com/event.asp?id=24367. The Web cast will be available for 30 days following the conference.

AAO Coblation Tonsillectomy Symposium

In conjunction with the AAO-HNSF Annual Meeting, ArthroCare will host a Coblation(R) tonsillectomy clinical symposium. Analysts and investors attending the meeting are invited to the symposium on a space available basis. Dr. David Walner -- pediatric otolaryngologist at Lutheran General Children's Hospital in Park Ridge, Ill. and assistant professor of otolaryngology/bronchoesophagology at Rush University Medical Center in Chicago -- will present clinical results from his practice comparing Coblation tonsillectomies versus Bovie tonsillectomies.

Specifically, Dr. Walner will discuss the patient benefits associated with Coblation tonsillectomies, including less pain, faster recovery and quicker return to regular diet. In addition, he will note his experiences with post-operative bleeding rates and show footage of past procedures.

Further details include:

--Date: Sun., Sept. 19, 2004

--Time: 12:00 p.m. EDT

--Location: Jacob K. Javits Convention Center, 655 West 34th Street, New York City 

--Room: AAO Annual Meeting Exhibit Area (Exhibitor badge required for entry.)

--RSVP to Katie Zarzana at 408-735-6253 or [e-mail], seating is limited.

ABOUT ARTHROCARE

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, Calif., is a multi-business medical device company that develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation technology. Coblation uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties, significantly improving surgical procedures and enabling new, minimally invasive procedures. ArthroCare's Coblation-based devices have been used in more than two million surgical procedures worldwide. The company has developed and marketed Coblation-based products for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic and laparoscopic/general surgical procedures, and continues research in other areas.

SAFE HARBOR STATEMENTS

Except for historical information, this press release includes forward-looking statements. These statements include, but are not limited to, the company's stated business outlook for fiscal 2004, continued strength of the company's fundamental position, the strength of the company's technology, the company's belief that strategic moves will enhance achievement of the company's long term potential, the potential and expected rate of growth of new businesses, continued success of product diversification efforts, and other statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to the uncertainty of success of the company's non-arthroscopic products, competitive risk, uncertainty of the success of strategic business alliances, uncertainty over reimbursement, need for governmental clearances or approvals before selling products, and the uncertainty of protecting the company's patent position. These and other risks and uncertainties are detailed from time to time in the company's Securities and Exchange Commission filings, including ArthroCare's Form 10-K for the year ended December 31, 2003 and the 10-Q for the quarter ended June 30, 2004. Forward-looking statements are indicated by words or phrases such as "anticipates," "estimates," "projects," "believes," "intends," "expects," and similar words and phrases. Actual results may differ materially from management expectations.